RELEASE: Sai Life Sciences publishes its 2022 Sustainability Report

(Information sent by the signatory company).

RELEASE: Sai Life Sciences publishes its 2022 Sustainability Report

(Information sent by the signatory company)

HYDERABAD, India, Dec. 6, 2022 /PRNewswire/ -- Sai Life Sciences, a leading global Contract Research, Development and Manufacturing Organization (CRO/CDMO), today announced the release of its 2022 Sustainability Report, prepared in accordance with the standards of the Global Reporting Initiative (GRI). Under the banner "Organizing for Sustainability Success," the Report outlines the company's efforts to progressively reduce the gap between knowing and doing by proactively addressing material sustainability-related issues. Read the full report here.

Making the announcement, Krishna Kanumuri, CEO and Managing Director, said, "In a context of climate change and recognition of the urgency of implementing development goals, Sai Life Sciences continues to turn promises into action in its pursuit of sustainability. Our 2022 Sustainability Report reflects sustained efforts in the economic, environmental and social arenas, and reiterates our ethos: "Improve Together".

The third report published by Sai Life Sciences reveals significant advances in multiple areas. Here are some of the highlights:

As part of its organizational transformation initiative, Sai Nxt, the company made significant progress in its sustainability program:

The company's Sustainable Development Goals (SDGs) were set in 2019 with a three-year timeframe ending in 2022. Incorporating the learnings from this period, the company is now in the process of envisioning goals and targets for the next phase. of your trip.

About Sai Life Sciences

Sai Life Sciences is a full-service CRO-CDMO working with innovative pharmaceutical and biotech companies around the world to accelerate the discovery, development and commercialization of complex small molecules. The company has more than 2,200 employees at its facilities in India, the United Kingdom and the United States. Sai Life Sciences is a private company backed by global investors TPG Capital and HBM Healthcare Investments. https://www.sailife.com/

Photo: https://mma.prnewswire.com/media/1961343...Logo: https://mma.prnewswire.com/media/1044186...

View original content: https://www.prnewswire.com/es/comunicados-de-prensa/sai-life-sciences-publica-su-informe-de-sostenibilidad-2022-301695611.html

NEXT NEWS